Related Experiment Video
Updated: Jul 19, 2026
14:49
Conducting Respiratory Oscillometry in an Outpatient Setting
Published on: April 8, 2022
High-frequency chest wall oscillation in ALS: an exploratory randomized, controlled trial.
D J Lange1, N Lechtzin, C Davey
1Department of Neurology, Mt. Sinai School of Medicine, One Gustave L. Levy Place, Box 1052, New York, NY 10029, USA. dale.lange@mssm.edu
Neurology
|September 27, 2006
Summary
High-frequency chest wall oscillation (HFCWO) improved breathlessness and reduced fatigue in ALS patients. This therapy was well-tolerated and showed a trend toward preserving lung function over 12 weeks.
Area of Science:
- Pulmonary Medicine
- Neurology
- Respiratory Therapy
Background:
- Amyotrophic Lateral Sclerosis (ALS) progressively impairs respiratory function, leading to significant morbidity.
- Effective management strategies are crucial for improving quality of life in ALS patients.
Purpose of the Study:
- To evaluate the impact of high-frequency chest wall oscillation (HFCWO) on respiratory function in patients with ALS.
- To assess changes in breathlessness, cough, and lung function parameters.
Main Methods:
- A 12-week randomized, controlled trial involving patients with probable or definite ALS.
- Participants had specific scores on the ALS Functional Rating Scale respiratory subscale and forced vital capacity (FVC).
- Comparison between an HFCWO group and an untreated control group.
Main Results:
- HFCWO users reported reduced breathlessness and increased nighttime coughing compared to baseline.
- A subgroup analysis indicated that HFCWO patients maintained FVC, unlike untreated patients.
- HFCWO demonstrated a trend toward slowing FVC decline and reducing fatigue and breathlessness in patients with moderate respiratory impairment.
Conclusions:
- High-frequency chest wall oscillation (HFCWO) is well-tolerated and beneficial for a majority of ALS patients.
- HFCWO effectively decreases breathlessness and fatigue in individuals with impaired respiratory function.
- The therapy shows potential in mitigating the decline of forced vital capacity in ALS.
Related Concept Videos
01:27Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
01:26Flail Chest-II
Managing flail chest, a condition characterized by a segment of the chest wall moving independently from the rest of the thoracic cage, requires a comprehensive approach. It includes a thorough assessment of the patient's condition, a diagnostic evaluation to determine the extent of the injury, and the implementation of appropriate medical interventions tailored to the individual's needs.
Assessment:
1. Clinical Evaluation:
History:
Assessment:
1. Clinical Evaluation:
History:
01:31Respiratory System Abnormal Finding II: Palpation and Auscultation
In assessing respiratory abnormalities, palpation and auscultation are critical tools for detecting and interpreting various pathophysiological changes. These techniques provide insight into underlying disorders by evaluating tactile sensations and sounds produced by the respiratory system.
Palpation Findings
During a respiratory assessment, palpation can reveal several vital abnormalities:
Palpation Findings
During a respiratory assessment, palpation can reveal several vital abnormalities:
01:24Chronic Obstructive Pulmonary Disease
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
01:26COPD: Management Using Bronchodilators and Corticosteroids
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
01:29Assessment of Ventilation II: Respiratory Depth and Rhythm
Respiratory Depth
Respiratory depth measures the volume of air inhaled or exhaled during a breath. It can vary from shallow to deep and typically remains consistent when a person is at rest or asleep. Occasionally, individuals will automatically inhale deeply, known as sighing, which inflates the lungs with more air than normal breathing.
To assess respiratory depth, observe the degree of chest excursion or movement:
Respiratory depth measures the volume of air inhaled or exhaled during a breath. It can vary from shallow to deep and typically remains consistent when a person is at rest or asleep. Occasionally, individuals will automatically inhale deeply, known as sighing, which inflates the lungs with more air than normal breathing.
To assess respiratory depth, observe the degree of chest excursion or movement: